Skift Take
If travel companies are not thinking about the impact of GLP-1s on their bottom line yet – in 2024 they will.
The Ozempic Era Will Force the Travel Industry to Adapt
If travel companies are not thinking about the impact of GLP-1s on their bottom line yet – in 2024 they will.
You have reached your limit of three free stories for the month. Your meter resets on June 16.
Already a subscriber? Login